The vaccines work. The COVID-19 vaccines continue to be remarkably effective in reducing risk of severe disease, hospitalization, and death, including against the delta variant. We continue to see highly effective protection against hospitalizations and severe outcomes for people who are fully vaccinated.
Booster doses are now recommended for some groups of people. The CDC recommends Pfizer boosters six months after their second dose for:
As the science and the virus evolves, so do our policies and recommendations. Booster doses are common for many vaccines. The scientists and medical experts who developed the COVID-19 vaccines continue to closely watch for signs of waning immunity, how well the vaccines protect against new mutations of the virus, and how that data differs across age groups and risk factors.
Millions of Americans are now eligible for booster shots, but there’s more guidance coming for others. Pfizer was the first vaccine to be authorized, and therefore its data on any waning effectiveness was also available first. Pfizer was the first vaccine to be authorized, and therefore its data on its ongoing effectiveness was also available first. Guidance is still forthcoming about boosters for the Johnson & Johnson and Moderna vaccines and the safety of mixing different vaccines.
Visit our Answers to Tough Questions on COVID-19 boosters for messaging guidance that helps answer questions such as: “Who should get a COVID-19 vaccine booster dose and why?” and “I want to get a booster dose, but I’m not eligible yet. Why not? Can I get one anyway?”
Sample Social Posts
Our booster dose toolkit also has new shareable graphics and sample posts, designed to support your vaccination outreach and answer questions in your community about the new booster dose guidance. Download and share them here. - Public Health Communications Collaborative
Webinars
COVID-19 Q&A WEBINAR
Join Surgeon General Vivek Murthy for a COVID-19 Response Update and Q&A on COVID-19 booster shots. If you would like to submit a question, please email us at covidcommunitycorps@hhs.gov,
and then RSVP below for the virtual event:
Date: Thursday, September 30th
Time: 5:00pm ET
RSVP here
The Public Health Workforce: Morale, Mental Health, and Moving Forward Webinar
Date: Wednesday, October 6, from 1 - 2 p.m. ET
This webinar with ongoing challenges of dealing with misinformation, political divides and even harassment that the public health workforce has faced throughout the pandemic. This timely conversation will feature Dr. Jeanette Kowalik, director of policy development at TFAH and Milwaukee’s former commissioner of health, Dr. Benjamin F. Miller, president of Well Being Trust, and Dr. Wilma J. Wooten, public health officer for the County of San Diego Health and Human Services Agency, and will be moderated by Dr. Lisa Waddell, chief medical officer of the CDC Foundation.
COVID-19 Economic Injury Disaster Loan (EIDL)
In response to COVID-19, small business owners, including agricultural businesses, and nonprofit organizations in all U.S. states, Washington D.C., and territories can apply for the COVID-19 Economic Injury Disaster Loan (EIDL). Check out SBA’s frequently asked questions and find more information here.
Educational Resources
COVID-19 Booster Shots
What you need to know about the Delta Variant
HHS - Coronavirus Information
Find a COVID-19 Vaccine Near You
Booster doses are now recommended for some groups of people. The CDC recommends Pfizer boosters six months after their second dose for:
- Older adults age 65+ and those living in long-term care facilities
- Adults ages 50-64 at high risk of severe COVID-19, due to underlying medical conditions
- Adults ages 18-49 at high risk of severe COVID-19 due to underlying medical conditions should consider a booster based on an assessment of their individual benefits and risks and consultation with their medical provider.
- Adults age 18-64 for people whose jobs put them at high risk for COVID-19
As the science and the virus evolves, so do our policies and recommendations. Booster doses are common for many vaccines. The scientists and medical experts who developed the COVID-19 vaccines continue to closely watch for signs of waning immunity, how well the vaccines protect against new mutations of the virus, and how that data differs across age groups and risk factors.
Millions of Americans are now eligible for booster shots, but there’s more guidance coming for others. Pfizer was the first vaccine to be authorized, and therefore its data on any waning effectiveness was also available first. Pfizer was the first vaccine to be authorized, and therefore its data on its ongoing effectiveness was also available first. Guidance is still forthcoming about boosters for the Johnson & Johnson and Moderna vaccines and the safety of mixing different vaccines.
Visit our Answers to Tough Questions on COVID-19 boosters for messaging guidance that helps answer questions such as: “Who should get a COVID-19 vaccine booster dose and why?” and “I want to get a booster dose, but I’m not eligible yet. Why not? Can I get one anyway?”
Sample Social Posts
Our booster dose toolkit also has new shareable graphics and sample posts, designed to support your vaccination outreach and answer questions in your community about the new booster dose guidance. Download and share them here. - Public Health Communications Collaborative
Webinars
COVID-19 Q&A WEBINAR
Join Surgeon General Vivek Murthy for a COVID-19 Response Update and Q&A on COVID-19 booster shots. If you would like to submit a question, please email us at covidcommunitycorps@hhs.gov,
and then RSVP below for the virtual event:
Date: Thursday, September 30th
Time: 5:00pm ET
RSVP here
The Public Health Workforce: Morale, Mental Health, and Moving Forward Webinar
Date: Wednesday, October 6, from 1 - 2 p.m. ET
This webinar with ongoing challenges of dealing with misinformation, political divides and even harassment that the public health workforce has faced throughout the pandemic. This timely conversation will feature Dr. Jeanette Kowalik, director of policy development at TFAH and Milwaukee’s former commissioner of health, Dr. Benjamin F. Miller, president of Well Being Trust, and Dr. Wilma J. Wooten, public health officer for the County of San Diego Health and Human Services Agency, and will be moderated by Dr. Lisa Waddell, chief medical officer of the CDC Foundation.
COVID-19 Economic Injury Disaster Loan (EIDL)
In response to COVID-19, small business owners, including agricultural businesses, and nonprofit organizations in all U.S. states, Washington D.C., and territories can apply for the COVID-19 Economic Injury Disaster Loan (EIDL). Check out SBA’s frequently asked questions and find more information here.
Educational Resources
COVID-19 Booster Shots
What you need to know about the Delta Variant
HHS - Coronavirus Information
Find a COVID-19 Vaccine Near You
